Carl Magnus Högerkorp
Keine laufenden Positionen mehr
Karriereverlauf von Carl Magnus Högerkorp
Ehemalige bekannte Positionen von Carl Magnus Högerkorp
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Vorstandsvorsitzender | 01.01.2019 | 01.04.2021 |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Vorstandsvorsitzender | 01.05.2017 | 01.10.2018 |
| XINTELA AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | 01.04.2017 |
| Immodulate Pharma AB | Vorstandsvorsitzender | 01.01.2021 | - |
| Gründer | 01.01.2021 | - | |
| CYXONE AB | Direktor/Vorstandsmitglied | 01.01.2023 | - |
| Vorstandsvorsitzender | 20.06.2022 | - | |
| Geschäftsführer | 20.05.2021 | 13.12.2022 | |
| Investor Relations Kontakt | - | - |
Ausbildung von Carl Magnus Högerkorp
| University of Lund | Doctorate Degree |
| Lund University School of Economics & Management | Masters Business Admin |
Statistik
International
| Schweden | 8 |
Operativ
| Chief Executive Officer | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XINTELA AB | Health Technology |
| CYXONE AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
Edvince AB
Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Health Technology |
| Immodulate Pharma AB |
- Börse
- Insiders
- Carl Magnus Högerkorp
- Erfahrung
